Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Capital Leases: 2014

  • Viridian Therapeutics, Inc.\DE's Capital Leases was N/A to $164,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $164,000, marking a year-over-year change of. This contributed to the annual value of $164,000 for FY2014, which is N/A change from last year.
  • Viridian Therapeutics, Inc.\DE's Capital Leases amounted to $164,000 in Q4 2014.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Capital Leases registered a high of $164,000 during Q4 2014, and its lowest value of $164,000 during Q4 2014.
  • In the last 1 years, Viridian Therapeutics, Inc.\DE's Capital Leases had a median value of $164,000 in 2014 and averaged $164,000.